Comment
doi: 10.1001/jamacardio.2016.0007.
The US Food and Drug Administration Premarket Approval Process and the 515 Program Initiative: View From a Panel Chair
Affiliations
- PMID: 27437880
- DOI: 10.1001/jamacardio.2016.0007
Item in Clipboard
Comment
The US Food and Drug Administration Premarket Approval Process and the 515 Program Initiative: View From a Panel Chair
JAMA Cardiol.
.
No abstract available
Comment on
-
The US Food and Drug Administration 515 Program Initiative: Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?JAMA Cardiol. 2016 May 1;1(2):117-8. doi: 10.1001/jamacardio.2016.0002. JAMA Cardiol. 2016. PMID: 27437879 No abstract available.
Similar articles
-
Transparency and Dermatologic Device Approval by the US Food and Drug Administration.JAMA Dermatol. 2018 Mar 1;154(3):273-280. doi: 10.1001/jamadermatol.2017.5757. JAMA Dermatol. 2018. PMID: 29365020 Free PMC article.
-
Premarket approval supplement pathway: do we know what we are getting?Ann Intern Med. 2014 Jun 3;160(11):798-9. doi: 10.7326/M13-2931. Ann Intern Med. 2014. PMID: 24664113 No abstract available.
-
Medtronic, Inc.; premarket approval of the Interstim Sacral Nerve Stimulation (SNS) System--FDA. Notice.Fed Regist. 1998 Jan 29;63(19):4457. Fed Regist. 1998. PMID: 10177327
-
Food and Drug Administration Efforts to Mitigate Contact Lens Discomfort.Eye Contact Lens. 2017 Jan;43(1):2-4. doi: 10.1097/ICL.0000000000000324. Eye Contact Lens. 2017. PMID: 27941360 Review.
-
Medical devices: US medical device regulation.Urol Oncol. 2015 Mar;33(3):128-32. doi: 10.1016/j.urolonc.2014.10.004. Epub 2014 Nov 6. Urol Oncol. 2015. PMID: 25458071 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
